Skip to main content

Table 3 Costs and probability of adverse events

From: Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis

 Abi-ADTDoc-ADTCost used in the model
Hypertension12120.3%  98.7
Hypokalaemia6210.4%  65.0
Increased ALT335.5%  225.7
Hyperglycaemia274.5%  115.0
Increased AST264.4%  225.7
Bone pain203.4%  73.6
Cardiac disorder223.7%  1000.0
Anaemia152.5%51.3%271.7
Back pain142.3%  73.6
Spinal-cord compression122.0%  1235.0
Fatigue101.7%164.1%540.4
Allergic reaction  82.1%75.0
Diarrhoea  41.0%31.4
Stomatitis  20.5%74.0
Neuropathy  41.0%375.8
Thromboembolism  30.8%1794.2
Sudden death  10.3%3200.0
Thrombocytopenia  10.3%3518.0
Neutropaenia  4712.1%720.8
Febrile neutropaenia  246.2%1787.2
Infection with neutropaenia  92.3%14,764.1